Gilead Sciences | Lånekapital



Loan Capital Lave om Dato
AbbVie USD 60.34B 1.83B 2024-12
Agios Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 54.01B 2.54B 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
J&J USD 38.36B 7.7B 2025-03
Merck USD 34.46B 520M 2024-12
Moderna USD 35M 4M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 13.41B 1.62B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Gilead Sciences Lånekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.